137 related articles for article (PubMed ID: 11258753)
21. Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease.
Labudova O; Kitzmueller E; Rink H; Cairns N; Lubec G
Clin Sci (Lond); 1999 Mar; 96(3):279-85. PubMed ID: 10029564
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of Herpes simplex virus types 1 and 2 in sera of patients with HSV central nervous system infections by type-specific enzyme-linked immunosorbent assay.
Nishimura Y; Ayabe M; Shoji H; Hashiguchi H; Eizuru Y; Kawana T
J Infect; 2001 Oct; 43(3):206-9. PubMed ID: 11798261
[TBL] [Abstract][Full Text] [Related]
23. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
25. Detection and differentiation of herpes simplex virus types 1 and 2 by a duplex LightCycler PCR that incorporates an internal control PCR reaction.
Whiley DM; Mackay IM; Syrmis MW; Witt MJ; Sloots TP
J Clin Virol; 2004 May; 30(1):32-8. PubMed ID: 15072751
[TBL] [Abstract][Full Text] [Related]
26. The impact of risk factors of Alzheimer's disease in the Down syndrome.
Folin M; Baiguera S; Conconi MT; Pati T; Grandi C; Parnigotto PP; Nussdorfer GG
Int J Mol Med; 2003 Feb; 11(2):267-70. PubMed ID: 12525890
[TBL] [Abstract][Full Text] [Related]
27. Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients.
La Rosa F; Agostini S; Bianchi A; Nemni R; Piancone F; Marventano I; Mancuso R; Saresella M; Clerici M
J Transl Med; 2019 Aug; 17(1):286. PubMed ID: 31455413
[TBL] [Abstract][Full Text] [Related]
28. Application of polymerase chain reaction to differentiate herpes simplex virus 1 and 2 serotypes in culture negative intraocular aspirates.
Shyamal G; Sowmya P; Sudha B; Malathi J; Therese LK; Madhavan HN
Indian J Med Microbiol; 2005 Oct; 23(4):239-44. PubMed ID: 16327119
[TBL] [Abstract][Full Text] [Related]
29. Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease.
Teipel SJ; Hampel H
Behav Genet; 2006 May; 36(3):405-15. PubMed ID: 16485178
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of herpes simplex virus DNA types 1 and 2 viral load in cerebrospinal fluid by real-time PCR in patients with herpes simplex encephalitis.
Schloss L; Falk KI; Skoog E; Brytting M; Linde A; Aurelius E
J Med Virol; 2009 Aug; 81(8):1432-7. PubMed ID: 19551833
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic significance of enzyme linked immuno-sorbent assay for herpes simplex, varicella zoster and cytomegalovirus retinitis.
Madhavan HN; Priya K
Indian J Ophthalmol; 2003 Mar; 51(1):71-5. PubMed ID: 12701866
[TBL] [Abstract][Full Text] [Related]
33. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.
Carter CJ
Neurochem Int; 2008 May; 52(6):920-34. PubMed ID: 18164103
[TBL] [Abstract][Full Text] [Related]
34. Down syndrome and Alzheimer's disease: a link between development and aging.
Lott IT; Head E
Ment Retard Dev Disabil Res Rev; 2001; 7(3):172-8. PubMed ID: 11553933
[TBL] [Abstract][Full Text] [Related]
35. Down syndrome, Alzheimer's disease and seizures.
Menéndez M
Brain Dev; 2005 Jun; 27(4):246-52. PubMed ID: 15862185
[TBL] [Abstract][Full Text] [Related]
36. Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease.
Mancuso R; Baglio F; Cabinio M; Calabrese E; Hernis A; Nemni R; Clerici M
J Alzheimers Dis; 2014; 38(4):741-5. PubMed ID: 24072067
[TBL] [Abstract][Full Text] [Related]
37. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1.
Hill JM; Steiner I; Matthews KE; Trahan SG; Foster TP; Ball MJ
Med Hypotheses; 2005; 64(1):53-8. PubMed ID: 15533611
[TBL] [Abstract][Full Text] [Related]
38. The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors.
Pyles RB
Herpes; 2001 Nov; 8(3):64-8. PubMed ID: 11867022
[TBL] [Abstract][Full Text] [Related]
39. Disrupting Neurons and Glial Cells Oneness in the Brain-The Possible Causal Role of Herpes Simplex Virus Type 1 (HSV-1) in Alzheimer's Disease.
Mielcarska MB; Skowrońska K; Wyżewski Z; Toka FN
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008671
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin GM genes as functional risk and protective factors for the development of Alzheimer's disease.
Pandey JP
J Alzheimers Dis; 2009; 17(4):753-6. PubMed ID: 19542624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
